JP2021534183A5 - - Google Patents
Info
- Publication number
- JP2021534183A5 JP2021534183A5 JP2021507907A JP2021507907A JP2021534183A5 JP 2021534183 A5 JP2021534183 A5 JP 2021534183A5 JP 2021507907 A JP2021507907 A JP 2021507907A JP 2021507907 A JP2021507907 A JP 2021507907A JP 2021534183 A5 JP2021534183 A5 JP 2021534183A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- composition according
- composition
- tubulin
- conjugate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862765099P | 2018-08-16 | 2018-08-16 | |
| US62/765,099 | 2018-08-16 | ||
| PCT/US2019/046944 WO2020037285A1 (en) | 2018-08-16 | 2019-08-16 | Method and composition for stimulating immune response |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021534183A JP2021534183A (ja) | 2021-12-09 |
| JP2021534183A5 true JP2021534183A5 (enExample) | 2022-08-24 |
Family
ID=69525893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021507907A Pending JP2021534183A (ja) | 2018-08-16 | 2019-08-16 | 免疫応答を刺激するための方法及び組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210177952A1 (enExample) |
| EP (1) | EP3836930A4 (enExample) |
| JP (1) | JP2021534183A (enExample) |
| KR (1) | KR20210047309A (enExample) |
| CN (1) | CN112638388A (enExample) |
| AU (1) | AU2019320830A1 (enExample) |
| CA (1) | CA3109223A1 (enExample) |
| MX (1) | MX2021001762A (enExample) |
| WO (1) | WO2020037285A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1249052A1 (zh) | 2015-03-06 | 2018-10-26 | BeyondSpring Pharmaceuticals Inc. | 治疗与ras突变相关的癌症的方法 |
| EP3334726B1 (en) | 2015-07-13 | 2022-03-16 | Beyondspring Pharmaceuticals, Inc. | Plinabulin compositions |
| EP4710947A3 (en) | 2016-01-08 | 2026-06-17 | Ascendis Pharma Growth Disorders A/S | Controlled-release cnp agonists with reduced side-effects |
| KR102518217B1 (ko) | 2016-01-08 | 2023-04-04 | 아센디스 파마 그로우쓰 디스오더스 에이/에스 | 낮은 npr-c 결합을 갖는 제어 방출성 cnp 작용제 |
| JP6968802B2 (ja) | 2016-01-08 | 2021-11-17 | アセンディス ファーマ グロース ディスオーダーズ エー／エス | 環部分にキャリア結合を有するｃｎｐプロドラッグ |
| CA3008015A1 (en) | 2016-01-08 | 2017-07-13 | Ascendis Pharma Growth Disorders A/S | Controlled-release c-type natriuretic peptide agonists with increased neutral endopeptidase stability |
| AU2017205693B2 (en) | 2016-01-08 | 2022-03-31 | Ascendis Pharma Growth Disorders A/S | Controlled-release CNP agonists with low initial NPR-B activity |
| US10912748B2 (en) | 2016-02-08 | 2021-02-09 | Beyondspring Pharmaceuticals, Inc. | Compositions containing tucaresol or its analogs |
| CN109475524A (zh) | 2016-06-06 | 2019-03-15 | 万春药业公司 | 用于减少中性粒细胞减少症的组合物和方法 |
| RU2768747C2 (ru) | 2016-09-29 | 2022-03-24 | Асцендис Фарма Гроус Дизордерс А/С | Комбинаторная терапия с агонистами cnp контролируемого высвобождения |
| WO2018129381A1 (en) | 2017-01-06 | 2018-07-12 | Beyondspring Pharmaceuticals, Inc. | Tubulin binding compounds and therapeutic use thereof |
| KR20190109479A (ko) | 2017-02-01 | 2019-09-25 | 비욘드스프링 파마수티컬스, 인코포레이티드. | 호중구감소증의 감소 방법 |
| WO2019147615A1 (en) | 2018-01-24 | 2019-08-01 | Beyondspring Pharmaceuticals, Inc. | Composition and method for reducing thrombocytopenia via the administration of plinabulin |
| EP4319751A4 (en) | 2021-04-09 | 2025-02-26 | Beyondspring Pharmaceuticals, Inc. | THERAPEUTIC COMPOSITIONS AND METHODS FOR THE TREATING OF TUMORS |
| CA3234699A1 (en) * | 2021-10-07 | 2023-04-13 | Beyondspring Pharmaceuticals, Inc. | Methods for treating cancers and tumors |
| US20250152473A1 (en) * | 2022-02-10 | 2025-05-15 | Beyondspring Pharmaceuticals, Inc. | Stable plinabulin formulations and methods of their preparation and use |
| CN117860672A (zh) | 2022-10-11 | 2024-04-12 | 大连万春布林医药有限公司 | 一种普那布林胶束组合物及其制备方法 |
| WO2025151374A1 (en) * | 2024-01-08 | 2025-07-17 | Beyondspring Pharmaceuticals, Inc. | Oncology combination therapy and methods of use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040197312A1 (en) * | 2003-04-02 | 2004-10-07 | Marina Moskalenko | Cytokine-expressing cellular vaccine combinations |
| WO2010101627A2 (en) * | 2009-03-02 | 2010-09-10 | Massachusetts Institute Of Technology | Methods and systems for treatment and/or diagnosis |
| CN101766815B (zh) * | 2009-12-31 | 2012-04-25 | 胡松华 | 紫杉醇及多西紫杉醇的用途 |
| WO2013124867A1 (en) * | 2012-02-21 | 2013-08-29 | Amrita Vishwa Vidyapeetham University | Polymer - polymer or polymer - protein core - shell nano medicine loaded with multiple drug molecules |
| MX394865B (es) * | 2015-02-12 | 2025-03-24 | Beyondspring Pharmaceuticals Inc | Uso de plinabulina en combinación con inhibidores de punto de control inmunitario |
| WO2018129381A1 (en) * | 2017-01-06 | 2018-07-12 | Beyondspring Pharmaceuticals, Inc. | Tubulin binding compounds and therapeutic use thereof |
-
2019
- 2019-08-16 KR KR1020217006506A patent/KR20210047309A/ko not_active Ceased
- 2019-08-16 AU AU2019320830A patent/AU2019320830A1/en not_active Abandoned
- 2019-08-16 EP EP19849560.8A patent/EP3836930A4/en not_active Withdrawn
- 2019-08-16 CA CA3109223A patent/CA3109223A1/en active Pending
- 2019-08-16 CN CN201980054515.0A patent/CN112638388A/zh active Pending
- 2019-08-16 MX MX2021001762A patent/MX2021001762A/es unknown
- 2019-08-16 US US17/268,380 patent/US20210177952A1/en not_active Abandoned
- 2019-08-16 WO PCT/US2019/046944 patent/WO2020037285A1/en not_active Ceased
- 2019-08-16 JP JP2021507907A patent/JP2021534183A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1946772B1 (en) | Multivalent vaccine composition | |
| Plotkin et al. | The development of vaccines: how the past led to the future | |
| JP4870895B2 (ja) | ワクチン組成物 | |
| Tahamtan et al. | An overview of history, evolution, and manufacturing of various generations of vaccines | |
| JP2004501873A5 (enExample) | ||
| AU4315693A (en) | Combined vaccines comprising hepatitis b surface antigen and other antigens | |
| EP2362781A1 (en) | Combination vaccine with acellular pertussis | |
| RU2013136397A (ru) | Комбинированная семивалентная вакцина | |
| JPH07300427A (ja) | 各ワクチン成分の免疫原性を増強した併用小児ワクチン | |
| RU2007142383A (ru) | Экспрессирующийся поверхностный антиген вируса гепатита в для получения вакцины | |
| Chavda et al. | History of vaccination | |
| JP2022511511A5 (enExample) | ||
| RU2021102185A (ru) | Способ и композиция для стимуляции иммунного ответа | |
| RU2014147491A (ru) | Антигены и антигенные композиции | |
| Akarsu et al. | Possible Cutaneous Adverse Effects of AntiInfective Vaccinations | |
| Hay | What you need to know | |
| Backx et al. | Immunization | |
| TW201008577A (en) | Vaccine composition | |
| Axelsen | Immunomodulators and Immunizing Agents | |
| Al-Jadiry | Childhood Immunization | |
| Parnham | opments in vaccinology will be outlined. | |
| Gonçalves et al. | Vaccination in autoimmune diseases | |
| Karen Phillips et al. | Immunization update: A 2011 retrospective on product changes and new recommendations | |
| Neuberger | Immunisation and Liver Transplantation | |
| Siegrist | The challenge of inducing protection in very young infants |